Vitavp takes the lead in applying Motivo synthetic nicotine technology to lead industrial upgrading
The “joint nicotine laboratory” initiated by Vitavp was listed in the R & D center of Nanshan District, Shenzhen. This joint laboratory is the first time vitavp has cooperated with a well-known high-tech group in the industry in the field of science and technology. Relying on Motivo’s patented technology of left-handed Synthetic Nicotine, the taste research, development and application of new Synthetic Nicotine electronic atomization solution will be carried out. The research on Synthetic Nicotine is one of the most concerned development trends in the field of electronic cigarette technology. At the same time, it also has high threshold technical requirements. Enterprises need to have sufficient R & D experience, industry cognition and large-scale application ability.
Based on Motivo technology patent, the joint laboratory will develop Synthetic Nicotine electronic atomization solution products. The electronic atomization liquid produced based on Motivo synthetic nicotine technology will minimize the user’s intake of nitroso and other inducement components that may lead to cell carcinogenesis. The Synthetic Nicotine of Motivo is based on the theory of organic drug synthesis and obtained through multi-step reaction directional synthesis under specific reaction conditions. Through laboratory certification, Synthetic Nicotine contains less impurities than natural nicotine, and does not contain four nitrosoamines, which is safer for human body.
Founded in 2015, vitavp started from the R & D and sales of atomizing liquid products and large smoke equipment to the independent R & D of small smoke products in early 2017. With years of technology accumulation, vitavp has become the first national high-tech enterprise in the field of electronic atomization in Beijing.
The data show that natural nicotine is levorotatory. Among the test methods included in the three pharmacopoeia for nicotine monographs, levorotatory is also pharmacologically active, and obtaining API quality control level levorotatory nicotine is the highest level requirement for synthetic nicotine. In the synthetic process of nicotine, racemate must be obtained first. Racemate is the intermediate product of the synthetic process and needs to be further separated and purified into left-handed product. In short, 5mg l-nicotine can produce the effect of 10mg racemic nicotine, with obvious cost advantage at the production end. In industrial production, the difficulty of quality control of residual solvents and impurities increases with the increase of reaction steps.
Therefore, the higher the quality of Synthetic Nicotine material, the more complex the preparation process is. At present, Synthetic Nicotine products in the market are divided into racemic and levo products. Motivo synthetic nicotine products have obtained levo synthetic nicotine through the preparation method of high optical purity nicotine (optical purity > 99.9%) and the new technology of Synthetic Nicotine. It is not only the levo product in the synthesis of nicotine, but also the API level in the levo product, At present, China and the United States have applied for invention patents.
We specialize in manufacturing chemical Synthetic Nicotine ( CAS No.: 54-11-5 ) in China. we have the highest technology and stable quality control , our factory has sophisticated technology production route to produce the above products ,welcome to inquiry it .Please contact us by e-mail email@example.com for quotation requests. Please provide quantity, purity, and any other specific requirements.http://www.synthetic-nicotine.net/vitavp-takes-the-lead-in-applying-motivo-synthetic-nicotine-technology-to-lead-industrial-upgrading/Synthetic Nicotine is used for E-Liquid